Increasing fatty acid oxidation remodels the hypothalamic neurometabolome to mitigate stress and inflammation.

Modification of hypothalamic fatty acid (FA) metabolism can improve energy homeostasis and prevent hyperphagia and excessive weight gain in diet-induced obesity (DIO) from a diet high in saturated fatty acids. We have shown previously that C75, a stimulator of carnitine palmitoyl transferase-1 (CPT-1) and fatty acid oxidation (FAOx), exerts at least some of its hypophagic effects via neuronal mechanisms in the hypothalamus. In the present work, we characterized the effects of C75 and another anorexigenic compound, the glycerol-3-phosphate acyltransferase (GPAT) inhibitor FSG67, on FA metabolism, metabolomics profiles, and metabolic stress responses in cultured hypothalamic neurons and hypothalamic neuronal cell lines during lipid excess with palmitate. Both compounds enhanced palmitate oxidation, increased ATP, and inactivated AMP-activated protein kinase (AMPK) in hypothalamic neurons in vitro. Lipidomics and untargeted metabolomics revealed that enhanced catabolism of FA decreased palmitate availability and prevented the production of fatty acylglycerols, ceramides, and cholesterol esters, lipids that are associated with lipotoxicity-provoked metabolic stress. This improved metabolic signature was accompanied by increased levels of reactive oxygen species (ROS), and yet favorable changes in oxidative stress, overt ER stress, and inflammation. We propose that enhancing FAOx in hypothalamic neurons exposed to excess lipids promotes metabolic remodeling that reduces local inflammatory and cell stress responses. This shift would restore mitochondrial function such that increased FAOx can produce hypothalamic neuronal ATP and lead to decreased food intake and body weight to improve systemic metabolism.
AuthorsJoseph W McFadden, Susan Aja, Qun Li, Veera V R Bandaru, Eun-Kyoung Kim, Norman J Haughey, Francis P Kuhajda, Gabriele V Ronnett
JournalPloS one (PLoS One) Vol. 9 Issue 12 Pg. e115642 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25541737 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 2-(nonylsulfonamido)benzoic acid
  • 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid
  • Appetite Depressants
  • Ceramides
  • Cholesterol Esters
  • Glycerides
  • Palmitates
  • Reactive Oxygen Species
  • Sulfonamides
  • ortho-Aminobenzoates
  • Adenosine Triphosphate
  • Glycerol-3-Phosphate O-Acyltransferase
  • AMP-Activated Protein Kinases
  • 4-Butyrolactone
  • 4-Butyrolactone (analogs & derivatives, pharmacology)
  • AMP-Activated Protein Kinases (metabolism)
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Appetite Depressants (pharmacology)
  • Cell Line
  • Cells, Cultured
  • Ceramides (metabolism)
  • Cholesterol Esters (metabolism)
  • Cricetinae
  • Glycerides (metabolism)
  • Glycerol-3-Phosphate O-Acyltransferase (antagonists & inhibitors)
  • Humans
  • Hypothalamus (cytology, metabolism)
  • Inflammation (metabolism)
  • Metabolome
  • Mice
  • Neurons (metabolism)
  • Oxidation-Reduction
  • Palmitates (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Stress, Physiological
  • Sulfonamides (chemistry, pharmacology)
  • ortho-Aminobenzoates (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: